ASSEMBLY BIOSCIENCES, INC. - 10-Q Filing
Assembly Biosciences reports third quarter 2025 financial results including significant R&D and G&A expenses.
Tickers: $ASMB
More Regulatory news
- Rain Enhancement Technologies Holdco, Inc. - 8-K Filing
- Star Equity Holdings, Inc. - 10-Q Filing
- Scribe Therapeutics, Inc. - 10-Q Filing
- RMR GROUP INC. - 10-K Filing
- Commercial Vehicle Group, Inc. - 8-K Filing
- CROWN CRAFTS INC - 10-Q Filing
- Avidbank Holdings, Inc. - 10-Q Filing
- SOLV Energy, Inc. - 10-Q Filing
- Cardiff Oncology, Inc. - 8-K Filing
- Ensysce Biosciences, Inc. - 8-K Filing